Search results (170)
« Back to NewsRDM researchers at IF Oxford Science and Ideas Festival
19 November 2024
Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
General MRC MHU MRC WIMM Publication Research
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Senior Fellowship awarded to Beth Psaila
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
General MRC MHU MRC WIMM Publication Research
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
General MRC MHU MRC WIMM Research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
New Fellow of the Academy of Medical Sciences
22 May 2024
Congratulations to Professor Adam Mead, who has been elected by the Academy of Medical Sciences to its fellowship.
Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects
16 May 2024
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.
Immunology at the MRC Weatherall Institute of Molecular Medicine
29 April 2024
For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit in the Weatherall Institute of Molecular Medicine (WIMM) speak about their research.
Professor Graham Ogg Receives Wellcome Discovery Award with International Team
16 April 2024
Awards General MRC TIDU MRC WIMM Research
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
Wellcome Career Development Awards for Betty Raman and Adam Wilkinson
15 April 2024
Awards CVM Department MRC WIMM
Associate Professors Betty Raman and Adam Wilkinson have both won an eight-year Wellcome Career Development Award to further their research.
Two Technician Champions appointed in the MRC WIMM
12 March 2024
We are delighted to announce that two members of the facilities staff at the MRC Weatherall Institute of Molecular Medicine have been chosen to act as Technician Champions.
World Cancer Day 2024: Highlighting cancer research at the MRC WIMM
4 February 2024
Department General MRC MHU MRC WIMM Research
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.